The risk or severity of adverse effects can be increased when epoprostenol is combined with bumetanide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with olanzapine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with methadone.


The risk or severity of adverse effects can be increased when D-mannitol is combined with cilazapril.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with salicylamide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with zonisamide.


The risk or severity of adverse effects can be increased when thiopental is combined with procaine.


The risk or severity of adverse effects can be increased when Bretylium is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Tramadol is combined with thiothixene.


The risk or severity of adverse effects can be increased when Tramadol is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when etodolac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when venlafaxine is combined with sertraline.


The risk or severity of adverse effects can be increased when pentazocine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when halothane is combined with nisoldipine.


The risk or severity of adverse effects can be increased when halothane is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when cocaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nabumetone is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when MELPERONE is combined with butamben.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when clonazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when equilin is combined with Echothiophate.


The risk or severity of adverse effects can be increased when clonazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when nicergoline is combined with oxymetholone.


The risk or severity of adverse effects can be increased when tiagabine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when prazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when Propiverine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when argatroban is combined with salicylic acid.


The risk or severity of adverse effects can be increased when clozapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when barnidipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with amisulpride.


The risk or severity of adverse effects can be increased when miconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when sotalol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with flunarizine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when benzocaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Torasemide is combined with allopurinol.


The risk or severity of adverse effects can be increased when Torasemide is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when methenamine is combined with sulfadiazine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ethotoin is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when pramipexole is combined with bumetanide.


The risk or severity of adverse effects can be increased when temazepam is combined with promazine.


The risk or severity of adverse effects can be increased when nimodipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Perospirone.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with cilazapril.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with duloxetine.


The risk or severity of adverse effects can be increased when midodrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with thioguanine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with fluoxetine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Olopatadine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when benzocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when butamben is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Perospirone is combined with scopolamine.


The risk or severity of adverse effects can be increased when thiopental is combined with HEROIN.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when cabergoline is combined with rasagiline.


The risk or severity of adverse effects can be increased when meperidine is combined with promethazine.


The risk or severity of adverse effects can be increased when meperidine is combined with clonazepam.


The risk or severity of adverse effects can be increased when atenolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when hydralazine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when zopiclone is combined with quazepam.


The risk or severity of adverse effects can be increased when topiramate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when clorazepate is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with thiopental.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when zopiclone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with digoxin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with sulpiride.


The risk or severity of adverse effects can be increased when ketorolac is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when benazepril is combined with leflunomide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with orphenadrine.


The risk or severity of adverse effects can be increased when hexetidine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with edrophonium.


The risk or severity of adverse effects can be increased when etoposide is combined with leflunomide.


The risk or severity of adverse effects can be increased when gabapentin is combined with clidinium.


The risk or severity of adverse effects can be increased when HEROIN is combined with methazolamide.


The risk or severity of adverse effects can be increased when HEROIN is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Perospirone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with 5-azacytidine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with pentazocine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when morphine is combined with phentolamine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when morphine is combined with flurazepam.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Demecarium.


The risk or severity of adverse effects can be increased when rasagiline is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when morphine is combined with furosemide.


The risk or severity of adverse effects can be increased when thioridazine is combined with sotalol.


The risk or severity of adverse effects can be increased when Butethal is combined with baclofen.


The risk or severity of adverse effects can be increased when Phenelzine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Etomidate is combined with etizolam.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when cabergoline is combined with methazolamide.


The risk or severity of adverse effects can be increased when temazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with docetaxel.


The risk or severity of adverse effects can be increased when rizatriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with allopurinol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when nitrazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with halothane.


The risk or severity of adverse effects can be increased when furosemide is combined with methyldopa.


The risk or severity of adverse effects can be increased when furazolidone is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with sotalol.


The risk or severity of adverse effects can be increased when lithium ion is combined with butalbital.


The risk or severity of adverse effects can be increased when cinnarizine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when furosemide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when furosemide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with diazepam.


The risk or severity of adverse effects can be increased when nimesulide is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Lurasidone.


The risk or severity of adverse effects can be increased when oxazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when zotepine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Lurasidone is combined with proparacaine.


The risk or severity of adverse effects can be increased when isradipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Halazepam.


The risk or severity of adverse effects can be increased when malathion is combined with methacholine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with efavirenz.


The risk or severity of adverse effects can be increased when isradipine is combined with quinapril.


The risk or severity of adverse effects can be increased when fenoprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with terazosin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when isradipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when carprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with terazosin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with paroxetine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with pancuronium.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with flurazepam.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Vecuronium.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with tiapride.


The risk or severity of adverse effects can be increased when docetaxel is combined with retinol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when oxiconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with moxifloxacin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Vilanterol.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with isoflurane.


The risk or severity of adverse effects can be increased when Clofarabine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with topiramate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with ethotoin.


The risk or severity of adverse effects can be increased when olanzapine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when furosemide is combined with Valrubicin.


The risk or severity of adverse effects can be increased when zopiclone is combined with citalopram.


The risk or severity of adverse effects can be increased when fenoprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when sulindac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when procyclidine is combined with pancuronium.


The risk or severity of adverse effects can be increased when bepridil is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when procyclidine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when reserpine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when reserpine is combined with ondansetron.


The risk or severity of adverse effects can be increased when celecoxib is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when cabergoline is combined with resveratrol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with butamben.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with zaleplon.


The risk or severity of adverse effects can be increased when cabergoline is combined with nicotinamide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when oxazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nilvadipine.


The risk or severity of adverse effects can be increased when isradipine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Alogliptin is combined with trandolapril.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when aspirin is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when methadone is combined with periciazine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when sulfisoxazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with clidinium.


The risk or severity of adverse effects can be increased when tolmetin is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Perospirone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when barnidipine is combined with brimonidine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Salsalate.


The risk or severity of adverse effects can be increased when butorphanol is combined with pimozide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tamoxifen.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with thioridazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with losartan.


The risk or severity of adverse effects can be increased when resveratrol is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with clidinium.


The risk or severity of adverse effects can be increased when fosinopril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Pipamperone is combined with topiramate.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with isradipine.


The risk or severity of adverse effects can be increased when fosinopril is combined with nabumetone.


The risk or severity of adverse effects can be increased when fosinopril is combined with ketorolac.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with zotepine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when sulpiride is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when amifostine is combined with clozapine.


The risk or severity of adverse effects can be increased when aspirin is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with furosemide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Normethadone.


The risk or severity of adverse effects can be increased when halothane is combined with cetirizine.


The risk or severity of adverse effects can be increased when selegiline is combined with Flupentixol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with trandolapril.


The risk or severity of adverse effects can be increased when bromocriptine is combined with rapamycin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when donepezil is combined with Cevimeline.


The risk or severity of adverse effects can be increased when oxymorphone is combined with furazolidone.


The risk or severity of adverse effects can be increased when thalidomide is combined with furosemide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Metipranolol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when topiramate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with citalopram.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with equilin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when codeine is combined with amobarbital.


The risk or severity of adverse effects can be increased when nefazodone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when dapsone is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with Olsalazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when aspirin is combined with Talniflumate.


The risk or severity of adverse effects can be increased when lorazepam is combined with butabarbital.


The risk or severity of adverse effects can be increased when glutethimide is combined with Normethadone.


The risk or severity of adverse effects can be increased when trazodone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when lorazepam is combined with temazepam.


The risk or severity of adverse effects can be increased when thalidomide is combined with diltiazem.


The risk or severity of adverse effects can be increased when cabergoline is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when Melatonin is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Propiverine is combined with meperidine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Levomepromazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Butethal is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with timolol.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with morphine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with miconazole.


The risk or severity of adverse effects can be increased when Asenapine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when ropinirole is combined with methyldopa.


The risk or severity of adverse effects can be increased when Lofexidine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when minoxidil is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nicardipine.


The risk or severity of adverse effects can be increased when metolazone is combined with hydralazine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when amcinonide is combined with physostigmine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with thiothixene.


The risk or severity of adverse effects can be increased when temazepam is combined with clorazepate.


The risk or severity of adverse effects can be increased when amcinonide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when losartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when losartan is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when losartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when rasagiline is combined with reserpine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when nimodipine is combined with propranolol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pramocaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when butorphanol is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Icatibant is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when vigabatrin is combined with dantrolene.


The risk or severity of adverse effects can be increased when methadone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when promethazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when sotalol is combined with quetiapine.


The risk or severity of adverse effects can be increased when benzphetamine is combined with selegiline.


The risk or severity of adverse effects can be increased when Etidocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with topiramate.


The risk or severity of adverse effects can be increased when loxapine is combined with imipramine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when quinidine is combined with butorphanol.


The risk or severity of adverse effects can be increased when halothane is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when captopril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when loxapine is combined with meperidine.


The risk or severity of adverse effects can be increased when Fondaparinux is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with salicylic acid.


The risk or severity of adverse effects can be increased when carisoprodol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when sulindac is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Voriconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when nabumetone is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when trandolapril is combined with nadolol.


The risk or severity of adverse effects can be increased when fosinopril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Etomidate is combined with butalbital.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Eletriptan is combined with amoxapine.


The risk or severity of adverse effects can be increased when citalopram is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when ethotoin is combined with vigabatrin.


The risk or severity of adverse effects can be increased when diclofenac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with amoxapine.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with tiapride.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Flibanserin.


The risk or severity of adverse effects can be increased when fosinopril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when tiagabine is combined with sertraline.


The risk or severity of adverse effects can be increased when periciazine is combined with thiopental.


The risk or severity of adverse effects can be increased when clidinium is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when reserpine is combined with captopril.


The risk or severity of adverse effects can be increased when ibuprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when cilazapril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with bromazepam.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Phenelzine.


The risk or severity of adverse effects can be increased when propofol is combined with ramipril.


The risk or severity of adverse effects can be increased when Arotinolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with prednisone.


The risk or severity of adverse effects can be increased when clomipramine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when nimodipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when reserpine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when tiapride is combined with amitriptyline.


The risk or severity of adverse effects can be increased when dopamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when tiapride is combined with Tolcapone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Articaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with metolazone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with efavirenz.


The risk or severity of adverse effects can be increased when Olmesartan is combined with aspirin.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when procyclidine is combined with dicyclomine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with lidocaine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with butorphanol.


The risk or severity of adverse effects can be increased when bepridil is combined with losartan.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when Trospium is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when resveratrol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Nabilone is combined with selegiline.


The risk or severity of adverse effects can be increased when bromazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when ethosuximide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with antipyrine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with pravastatin.


The risk or severity of adverse effects can be increased when epirizole is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with loratadine.


The risk or severity of adverse effects can be increased when lidocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when lidocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when hydralazine is combined with penbutolol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with imipramine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Pizotifen.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with formestane.


The risk or severity of adverse effects can be increased when halothane is combined with papaverine.


The risk or severity of adverse effects can be increased when thiamylal is combined with paroxetine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when halothane is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when halothane is combined with nifedipine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Butethal is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Difenoxin is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when midazolam is combined with pimozide.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when tolterodine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when codeine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with doxepin.


The risk or severity of adverse effects can be increased when procarbazine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when sulconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with tizanidine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Trospium is combined with Normethadone.


The risk or severity of adverse effects can be increased when flurazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when sulindac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when amiodarone is combined with Olmesartan.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with diazepam.


The risk or severity of adverse effects can be increased when protriptyline is combined with isoetharine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when amobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when amobarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when pancuronium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when sertraline is combined with periciazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitrofurantoin is combined with prilocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when nicergoline is combined with losartan.


The risk or severity of adverse effects can be increased when carprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when morphine is combined with trandolapril.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with potassium ion.


The risk or severity of adverse effects can be increased when oxybutynin is combined with morphine.


The risk or severity of adverse effects can be increased when proparacaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Telmisartan.


The risk or severity of adverse effects can be increased when medrysone is combined with malathion.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Nabilone is combined with methazolamide.


The risk or severity of adverse effects can be increased when oxycodone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Droxicam.


The risk or severity of adverse effects can be increased when mecamylamine is combined with tolterodine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with quetiapine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Eprosartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when bupivacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Mometasone.


The risk or severity of adverse effects can be increased when halothane is combined with butalbital.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when apomorphine is combined with isradipine.


The risk or severity of adverse effects can be increased when tiapride is combined with Retigabine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when etodolac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with mefloquine.


The risk or severity of adverse effects can be increased when baclofen is combined with Escitalopram.


The risk or severity of adverse effects can be increased when baclofen is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when pramipexole is combined with furosemide.


The risk or severity of adverse effects can be increased when betaxolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when quazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amoxapine is combined with citalopram.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when felbamate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when quazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Eletriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when morniflumate is combined with salicylic acid.


The risk or severity of adverse effects can be increased when acebutolol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when haloperidol is combined with triazolam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with phenindione.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tolazoline.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Nabilone is combined with doxazosin.


The risk or severity of adverse effects can be increased when risperidone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when haloperidol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when loxapine is combined with tiapride.


The risk or severity of adverse effects can be increased when carprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when topiramate is combined with promethazine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Icatibant.


The risk or severity of adverse effects can be increased when fenbufen is combined with amcinonide.


The risk or severity of adverse effects can be increased when irbesartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when desipramine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with dantrolene.


The risk or severity of adverse effects can be increased when diazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when butorphanol is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with phenytoin.


The risk or severity of adverse effects can be increased when morniflumate is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when benazepril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when benzocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when spironolactone is combined with prazosin.


The risk or severity of adverse effects can be increased when pancuronium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when enflurane is combined with paroxetine.


The risk or severity of adverse effects can be increased when phentolamine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when butorphanol is combined with clomipramine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when benzocaine is combined with imipramine.


The risk or severity of adverse effects can be increased when apomorphine is combined with fosinopril.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with tetracaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Indacaterol.


The risk or severity of adverse effects can be increased when D-mannitol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Naftifine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Articaine.


The risk or severity of adverse effects can be increased when methazolamide is combined with carvedilol.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nalbuphine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with antipyrine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nicardipine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with clonidine.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Trospium is combined with Pentolinium.


The risk or severity of adverse effects can be increased when loxapine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when halothane is combined with maprotiline.


The risk or severity of adverse effects can be increased when reserpine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when loxapine is combined with zopiclone.


The risk or severity of adverse effects can be increased when diltiazem is combined with propranolol.


The risk or severity of adverse effects can be increased when reserpine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when enflurane is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with methazolamide.


The risk or severity of adverse effects can be increased when ketorolac is combined with carprofen.


The risk or severity of adverse effects can be increased when Tramadol is combined with levorphanol.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ramipril.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when pargyline is combined with dobutamine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with vincristine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with penbutolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Butethal.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when loxapine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when medrysone is combined with mefloquine.


The risk or severity of adverse effects can be increased when etodolac is combined with acemetacin.


The risk or severity of adverse effects can be increased when spiramycin is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when azelastine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when dyclonine is combined with imipramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with loratadine.


The risk or severity of adverse effects can be increased when azelastine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when dicyclomine is combined with pancuronium.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when thioridazine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when morphine is combined with tiagabine.


The risk or severity of adverse effects can be increased when docetaxel is combined with resveratrol.


The risk or severity of adverse effects can be increased when morphine is combined with ondansetron.


The risk or severity of adverse effects can be increased when haloprogin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when floctafenine is combined with resveratrol.


The risk or severity of adverse effects can be increased when Halazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Halazepam.


The risk or severity of adverse effects can be increased when isradipine is combined with furosemide.


The risk or severity of adverse effects can be increased when thioridazine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when thioridazine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when isradipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when ibudilast is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when epirizole is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when epirizole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when memantine is combined with nicotine.


The risk or severity of adverse effects can be increased when methysergide is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when diclofenac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with galanthamine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with thiothixene.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when oxazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when lisinopril is combined with nadolol.


The risk or severity of adverse effects can be increased when Limaprost is combined with ticlopidine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when midazolam is combined with proparacaine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with zotepine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with primidone.


The risk or severity of adverse effects can be increased when midazolam is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when etizolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when midazolam is combined with Halazepam.


The risk or severity of adverse effects can be increased when morniflumate is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when nitrazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with butalbital.


The risk or severity of adverse effects can be increased when doxepin is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when butabarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiopental is combined with ondansetron.


The risk or severity of adverse effects can be increased when thiopental is combined with cocaine.


The risk or severity of adverse effects can be increased when thiopental is combined with tiagabine.


The risk or severity of adverse effects can be increased when linezolid is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when moclobemide is combined with zotepine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when thiopental is combined with zonisamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Pramocaine.


The risk or severity of adverse effects can be increased when brimonidine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when retinol is combined with tretinoin.


The risk or severity of adverse effects can be increased when glutethimide is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when topiramate is combined with duloxetine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Articaine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with betaxolol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Rufinamide is combined with zaleplon.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with fenbufen.


The risk or severity of adverse effects can be increased when ketamine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triazolam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with triprolidine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with acebutolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with primidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tolazoline.


The risk or severity of adverse effects can be increased when quazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when dexamethasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when nicardipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when bifonazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Mirabegron.


The risk or severity of adverse effects can be increased when phentolamine is combined with ropinirole.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Vecuronium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Halazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when clozapine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when butabarbital is combined with oxycodone.


The risk or severity of adverse effects can be increased when butabarbital is combined with buspirone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nystatin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with terazosin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when nabumetone is combined with Icatibant.


The risk or severity of adverse effects can be increased when nitric oxide is combined with butalbital.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Eprosartan is combined with irbesartan.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with clemastine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Demecarium.


The risk or severity of adverse effects can be increased when Eprosartan is combined with felodipine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with triamterene.


The risk or severity of adverse effects can be increased when rescinnamine is combined with suprofen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with butalbital.


The risk or severity of adverse effects can be increased when propoxyphene is combined with selegiline.


The risk or severity of adverse effects can be increased when ketorolac is combined with budesonide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with etizolam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Riociguat.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with terazosin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with butamben.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with cytarabine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with betamethasone.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with morphine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when protriptyline is combined with triprolidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with clidinium.


The risk or severity of adverse effects can be increased when phenylephrine is combined with dobutamine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with atenolol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when reserpine is combined with trazodone.


The risk or severity of adverse effects can be increased when reserpine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when reserpine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when nadolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with hydralazine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when amiodarone is combined with propafenone.


The risk or severity of adverse effects can be increased when Tramadol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when cetirizine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when levodopa is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with ondansetron.


The risk or severity of adverse effects can be increased when nicergoline is combined with vinblastine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with edrophonium.


The risk or severity of adverse effects can be increased when rasagiline is combined with moclobemide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with acetazolamide.


The risk or severity of adverse effects can be increased when buspirone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Propiverine is combined with morphine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Salsalate.


The risk or severity of adverse effects can be increased when paramethasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when tolmetin is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when diltiazem is combined with apraclonidine.


The risk or severity of adverse effects can be increased when diltiazem is combined with Telmisartan.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when secobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when docetaxel is combined with PONATINIB.


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when perphenazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with formestane.


The risk or severity of adverse effects can be increased when methadone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with resveratrol.


The risk or severity of adverse effects can be increased when amobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when venlafaxine is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when Spirapril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when quetiapine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when ethopropazine is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Etomidate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when temazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Conivaptan is combined with lisinopril.


The risk or severity of adverse effects can be increased when THYMOL is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when alclofenac is combined with budesonide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nicardipine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with clidinium.


The risk or severity of adverse effects can be increased when barnidipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with decamethonium.


The risk or severity of adverse effects can be increased when trazodone is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with clomipramine.


The risk or severity of adverse effects can be increased when biperiden is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when bumetanide is combined with netilmicin.


The risk or severity of adverse effects can be increased when perphenazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when scopolamine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when meperidine is combined with topiramate.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Pinaverium.


The risk or severity of adverse effects can be increased when felbamate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with imipramine.


The risk or severity of adverse effects can be increased when morphine is combined with butalbital.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Halazepam.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when furosemide is combined with nifedipine.


The risk or severity of adverse effects can be increased when butamben is combined with primidone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with diltiazem.


The risk or severity of adverse effects can be increased when paroxetine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with protriptyline.


The risk or severity of adverse effects can be increased when levorphanol is combined with ketamine.


The risk or severity of adverse effects can be increased when levorphanol is combined with quetiapine.


The risk or severity of adverse effects can be increased when tetracaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tetracaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with triamcinolone.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Tramadol.


The risk or severity of adverse effects can be increased when thioridazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with nimesulide.


The risk or severity of adverse effects can be increased when suprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when rasagiline is combined with Rotigotine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with felodipine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with loratadine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Salsalate.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with irbesartan.


The risk or severity of adverse effects can be increased when Olmesartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Bretylium.


The risk or severity of adverse effects can be increased when tolmetin is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when selegiline is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ropinirole is combined with apraclonidine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when ALENDRONIC ACID is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with citalopram.


The risk or severity of adverse effects can be increased when enflurane is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Articaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with fleroxacin.


The risk or severity of adverse effects can be increased when pentazocine is combined with clonazepam.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when cocaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when ketamine is combined with lidocaine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Difenoxin.


The risk or severity of adverse effects can be increased when imipramine is combined with scopolamine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with butamben.


The risk or severity of adverse effects can be increased when imipramine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when tolmetin is combined with Mometasone.


The risk or severity of adverse effects can be increased when thioridazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with terazosin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ILOPROST.


The risk or severity of adverse effects can be increased when dibucaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when prazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when SIMEPREVIR is combined with meperidine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with gabapentin.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Indacaterol.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when bepridil is combined with Sacubitril.


The risk or severity of adverse effects can be increased when levorphanol is combined with primidone.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Cariprazine.


The risk or severity of adverse effects can be increased when pargyline is combined with methadone.


The risk or severity of adverse effects can be increased when indomethacin is combined with equilin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with ketoprofen.


The risk or severity of adverse effects can be increased when sulpiride is combined with Melatonin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with quazepam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with prazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with trimipramine.


The risk or severity of adverse effects can be increased when amprenavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when enalapril is combined with antipyrine.


The risk or severity of adverse effects can be increased when imipramine is combined with morphine.


The risk or severity of adverse effects can be increased when alprazolam is combined with prazepam.


The risk or severity of adverse effects can be increased when betamethasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when enalapril is combined with quetiapine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with indomethacin.


The risk or severity of adverse effects can be increased when lisinopril is combined with carvedilol.


The risk or severity of adverse effects can be increased when lorazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when thalidomide is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when thalidomide is combined with metolazone.


The risk or severity of adverse effects can be increased when lorazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with morphine.


The risk or severity of adverse effects can be increased when Articaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Olsalazine is combined with loteprednol.


The risk or severity of adverse effects can be increased when sotalol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with antipyrine.


The risk or severity of adverse effects can be increased when sulconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when quazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with domperidone.


The risk or severity of adverse effects can be increased when quazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when ambenonium is combined with pilocarpine.


The risk or severity of adverse effects can be increased when quazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when zotepine is combined with butamben.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Asenapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when furosemide is combined with quetiapine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Difenoxin.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when amisulpride is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with mesoridazine.


The risk or severity of adverse effects can be increased when furosemide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with clemastine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when cetirizine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when oxycodone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when pimozide is combined with clonidine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when triamterene is combined with quetiapine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Articaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Boceprevir is combined with meperidine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when vigabatrin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when mepivacaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Udenafil.


The risk or severity of adverse effects can be increased when imipramine is combined with procarbazine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with halothane.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with betamethasone.


The risk or severity of adverse effects can be increased when nimesulide is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with irbesartan.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Nabilone.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with dorzolamide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with sotalol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when THYMOL is combined with eperisone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with tetracaine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pentyl nitrite.